BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 15077314)

  • 1. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.
    Del Papa N; Colombo G; Fracchiolla N; Moronetti LM; Ingegnoli F; Maglione W; Comina DP; Vitali C; Fantini F; Cortelezzi A
    Arthritis Rheum; 2004 Apr; 50(4):1296-304. PubMed ID: 15077314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair.
    Elshal M; Abdelaziz A; Abbas A; Mahmoud K; Fathy H; El Mongy S; El-Basyuoni S; Ahmed H; McCoy P
    Nephrol Dial Transplant; 2009 May; 24(5):1495-9. PubMed ID: 19039027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Raised levels of circulating endothelial cells in systemic sclerosis].
    Del Papa N; Cortiana M; Maglione W; Comina DP; Silvestris I; Moronetti Mazzeo L; Fracchiolla N; Fantini F; Cortelezzi A
    Reumatismo; 2005; 57(1):29-35. PubMed ID: 15776144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity.
    Avouac J; Juin F; Wipff J; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
    Ann Rheum Dis; 2008 Oct; 67(10):1455-60. PubMed ID: 18174219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis.
    Del Papa N; Cortiana M; Vitali C; Silvestris I; Maglione W; Comina DP; Lucchi T; Cortelezzi A
    J Rheumatol; 2008 Jul; 35(7):1323-8. PubMed ID: 18528965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis.
    Guiducci S; Distler JH; Jüngel A; Huscher D; Huber LC; Michel BA; Gay RE; Pisetsky DS; Gay S; Matucci-Cerinic M; Distler O
    Arthritis Rheum; 2008 Sep; 58(9):2845-53. PubMed ID: 18759303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunction.
    Boos CJ; Balakrishnan B; Lip GY
    Ann Med; 2008; 40(1):66-73. PubMed ID: 17934907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased lymphatic vessel counts in patients with systemic sclerosis: association with fingertip ulcers.
    Akhmetshina A; Beer J; Zwerina K; Englbrecht M; Palumbo K; Dees C; Reich N; Zwerina J; Szucs G; Gusinde J; Nevskaya T; Distler O; Kerjaschki D; Schett G; Distler JH
    Arthritis Rheum; 2010 May; 62(5):1513-22. PubMed ID: 20155824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating endothelial cells in patients with chronic lymphocytic leukemia.
    Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA
    Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.
    Avouac J; Wipff J; Goldman O; Ruiz B; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
    Arthritis Rheum; 2008 Nov; 58(11):3550-61. PubMed ID: 18975312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis.
    Manetti M; Neumann E; Müller A; Schmeiser T; Saar P; Milia AF; Endlicher E; Roeb E; Messerini L; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U
    Arthritis Rheum; 2008 Sep; 58(9):2866-73. PubMed ID: 18759276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis.
    Campioni D; Lo Monaco A; Lanza F; Moretti S; Ferrari L; Fotinidi M; La Corte R; Cuneo A; Trotta F
    Haematologica; 2008 Aug; 93(8):1233-7. PubMed ID: 18556411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating endothelial cells in preeclampsia.
    Canbakan B; Keven K; Tutkak H; Danisman N; Ergun I; Nergizoglu G
    J Hum Hypertens; 2007 Jul; 21(7):558-63. PubMed ID: 17429447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.
    Apras S; Ertenli I; Ozbalkan Z; Kiraz S; Ozturk MA; Haznedaroglu IC; Cobankara V; Pay S; Calguneri M
    Arthritis Rheum; 2003 Aug; 48(8):2256-61. PubMed ID: 12905480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial injury and repair in systemic vasculitis of the young.
    Clarke LA; Hong Y; Eleftheriou D; Shah V; Arrigoni F; Klein NJ; Brogan PA
    Arthritis Rheum; 2010 Jun; 62(6):1770-80. PubMed ID: 20178138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement.
    Del Rosso A; Distler O; Milia AF; Emanueli C; Ibba-Manneschi L; Guiducci S; Conforti ML; Generini S; Pignone A; Gay S; Madeddu P; Matucci-Cerinic M
    Ann Rheum Dis; 2005 Mar; 64(3):382-7. PubMed ID: 15708892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
    Goodale D; Phay C; Brown W; Gray-Statchuk L; Furlong P; Lock M; Chin-Yee I; Keeney M; Allan AL
    Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.